UNSPSC 51281645: Dibekacin sulfate

This classification denotes an aminoglycoside antibiotic with the molecular formula C18H37N5O8.H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A0869I992Z, chemically known as d-streptamine, o-3-amino-3-deoxy-alpha-d-glucopyranosyl-(1-6)-o-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-d-erythro-hexopyranosyl-(1-4))-2-deoxy-, sulfate (salt) but more generally known as dibekacin sulfate, which bears US NIH Compound Identifier 162862.

UNSPSC 51281645 Dibekacin sulfate is a Commodity code nominally identifying a single pharmaceutical product, but recent state and local solicitations tagged with this code show minimal relevant activity — the most recent opportunities under the code address naloxone procurement, direct-to-manufacturer prescription programs, general medical and first aid supplies for emergency response, and multi-source generic pharmaceuticals through cooperative purchasing vehicles, none of which involve dibekacin sulfate specifically. The mismatch between the code's scope and actual recent procurement activity suggests this Commodity code does not reflect the primary vehicles through which state and local governments are currently sourcing pharmaceutical products in this therapeutic area.

The limited recent activity under this code spans three distinct issuing bodies and procurement approaches: Seminole County, Florida issued an IFB (due July 26, 2023) for naloxone and drug deactivation systems; the Texas Health and Human Services Commission posted an RFI (April 3, 2026) exploring direct-to-manufacturer prescription capabilities; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) released an RFP (due March 26, 2026) for generic multi-source pharmaceuticals through authorized wholesalers serving Minnesota, Oregon, and other participating jurisdictions. Activity appears concentrated in cooperative purchasing arrangements and state health agency procurement rather than municipal or county-level direct buys for this specific product category. The geographic spread spans Florida, Texas, and Minnesota-led multi-state procurement, with broader access through MMCAP participation.